Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Background: It is unclear whether antidepressants can prevent suicides or suicide attempts, particularly during long-term use. Methods: We carried out a comprehensive review of long-term studies of antidepressants (relapse prevention). Sources were obtained from 5 review articles and by searches of MEDLINE, PubMed Central and a hand search of bibliographies. We meta-analyzed placebo-controlled antidepressant RCTs of at least 3 months' duration and calculated suicide and suicide attempt incidence rates, incidence rate ratios and Peto odds ratios (ORs). Results: Out of 807 studies screened 29 were included, covering 6,934 patients (5,529 patient-years). In total, 1.45 suicides and 2.76 suicide attempts per 1,000 patient-years were reported. Seven out of 8 suicides and 13 out of 14 suicide attempts occurred in antidepressant arms, resulting in incidence rate ratios of 5.03 (0.78-114.1; p = 0.102) for suicides and of 9.02 (1.58-193.6; p = 0.007) for suicide attempts. Peto ORs were 2.6 (0.6-11.2; nonsignificant) and 3.4 (1.1-11.0; p = 0.04), respectively. Dropouts due to unknown reasons were similar in the antidepressant and placebo arms (9.6 vs. 9.9%). The majority of suicides and suicide attempts originated from 1 study, accounting for a fifth of all patient-years in this meta-analysis. Leaving out this study resulted in a nonsignificant incidence rate ratio for suicide attempts of 3.83 (0.53-91.01). Conclusions: Therapists should be aware of the lack of proof from RCTs that antidepressants prevent suicides and suicide attempts. We cannot conclude with certainty whether antidepressants increase the risk for suicide or suicide attempts. Researchers must report all suicides and suicide attempts in RCTs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large survey conducted in the United States, MDD was associated with 27.2 workdays lost per affected worker per year 204 .”
From Major depressive disorder (2016) · cites this paper as [204]
Citations
Cites
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Blumenthal, J. A., Babyak, M. A., Doraiswamy, P. M., Watkins, L., Hoffman, B. M., Barbour, K. A., Herman, S., Craighead, W. E., Brosse, A. L., Waugh, R., et al. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318148c19a · Cited by 1,019
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Reynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia
Inskip, H., Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.35 · Cited by 579
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Khan, A., Warner, H. A., & Brown, W. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.311 · Cited by 477
Khan, A., Khan, S., Kolts, R., & Brown, W. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.790 · Cited by 394
The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
Wasserman, D., Rihmer, Z., Rujescu, D., Sarchiapone, M., Sokolowski, M., Titelman, D., Zalsman, G., Zemishlany, Z., & Carli, V. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.06.003 · Cited by 390
Gunnell, D., Saperia, J., & Ashby, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.385 · Cited by 387
Goodwin, G. M., Emsley, R., Rembry, S., Rouillon, F., & the Agomelatine Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04548 · Cited by 340
Schaffer, A., Isometsä, E. T., Tondo, L., H Moreno, D., Turecki, G., Reis, C., Cassidy, F., Sinyor, M., Azorin, J., Kessing, L. V., et al. (2015) · Bipolar Disorders · doi:10.1111/bdi.12271 · Cited by 335
Angst, J., Angst, F., Gerber-Werder, R., & Gamma, A. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929488 · Cited by 318
Suicidal Behaviour in Mood Disorders—Who, When, and Why?
Isometsä, E. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900303 · Cited by 310
Oquendo, M. A., Currier, D., & Mann, J. J. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00829.x · Cited by 296
Gibbons, R. D., Brown, C. H., Hur, K., Davis, J. M., & Mann, J. J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2048 · Cited by 291
Sertraline in the Prevention of Depression
Doogan, D. P., & Caillard, V. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.217 · Cited by 245
Risk factors for fatal and nonfatal repetition of suicide attempts: A literature review
Cornaggia, C., Beghi, Rosenbaum, & Cerri (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s40213 · Cited by 208
Lustman, P. J., Clouse, R. E., Nix, B. D., Freedland, K. E., Rubin, E. H., McGill, J. B., Williams, M. M., Gelenberg, A. J., Ciechanowski, P. S., & Hirsch, I. B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.521 · Cited by 202
The suicide prevention effect of lithium: more than 20 years of evidence—a narrative review
Lewitzka, U., Severus, E., Bauer, R., Ritter, P., Müller-Oerlinghausen, B., & Bauer, M. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0032-2 · Cited by 196
Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
Montgomery, S. A., & Dunbar, G. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00009 · Cited by 188
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., Rush, A. J., Tao, R., & Rintelmann, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091453 · Cited by 188
Long‐term suicide risk of depression in the Lundby cohort 1947–1997 – severity and gender
Brådvik, L., Mattisson, C., Bogren, M., & Nettelbladt, P. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01136.x · Cited by 165
Montgomery, S. A., Rasmussen, J. G. C., & Tanghøj, P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00008 · Cited by 163
Old Age Depression Interest Group, Jacoby, R., Lunn, A. D., Ardern, M., Bergmann, K., Conway, J., Cooling, N., Davies, G., Fisk, J., Gehlhaar, E., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.2.175 · Cited by 155
Kok, R. M., Heeren, T. J., & Nolen, W. A. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ec8085 · Cited by 141
Suicide Rates in Short-term Randomized Controlled Trials of Newer Antidepressants
Hammad, T. A., Laughren, T. P., & Racoosin, J. A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203198.11453.95 · Cited by 128
Suicidal antidepressant overdoses: A comparative analysis by antidepressant type
White, N. C., Litovitz, T., & Clancy, C. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03161207 · Cited by 117
Suicide Risk in Placebo-Controlled Studies of Major Depression
Storosum, J. G., van Zwieten, B. J., van den Brink, W., Gersons, B. P. R., & Broekmans, A. W. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1271 · Cited by 112
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
McGrath, P. J., Stewart, J. W., Quitkin, F. M., Chen, Y., Alpert, J. E., Nierenberg, A. A., Fava, M., Cheng, J., & Petkova, E. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1542 · Cited by 111
Klysner, R., Bent-Hansen, J., Hansen, H. L., Lunde, M., Pleidrup, E., Poulsen, D. L., Andersen, M., & Petersen, H. E. H. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.1.29 · Cited by 106
Meta-analysis of relapse prevention antidepressant trials in depressive disorders
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048671003705441 · Cited by 100
Khan, A., Khan, S. R., Leventhal, R. M., & Brown, W. A. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002322 · Cited by 98
Meta-analysis of incidence of rare events
Lane, P. W. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280211432218 · Cited by 97
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Perahia, D. G., Gilaberte, I., Wang, F., Wiltse, C. G., Huckins, S. A., Clemens, J. W., Montgomery, S. A., Montejo, A. L., & Detke, M. J. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.346 · Cited by 94
Maund, E., Tendal, B., Hrobjartsson, A., Jorgensen, K. J., Lundh, A., Schroll, J., & Gotzsche, P. C. (2014) · BMJ · doi:10.1136/bmj.g3510 · Cited by 88
Versiani, M., Mehilane, L., Gaszner, P., Arnaud-Castiglioni, R., & The Metrifonate Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0610 · Cited by 88
Thase, M. E., Nierenberg, A. A., Keller, M. B., & John Panagides for the Relapse Prevention Study Group (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1006 · Cited by 85
Lépine, J.-P., Caillard, V., Bisserbe, J.-C., Troy, S., Hotton, J.-M., Boyer, P., & For the PREVERS Investigators (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.836 · Cited by 83
[Recurrence of unipolar depression and efficacy of maprotiline].
Rouillon, F., Phillips, R., Serrurier, D., Ansart, E., & Mj, G. (1989) · PubMed · Cited by 81
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.31 · Cited by 75
Feiger, A. D., Bielski, R. J., Bremner, J., Heiser, J. F., Trivedi, M., Wilcox, C. S., Roberts, D. L., Kensler, T. T., McQuade, R. D., Kaplita, S. B., et al. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199901000-00002 · Cited by 74
Relapse rates with long‐term antidepressant drug therapy: a meta‐analysis
Williams, N., Simpson, A. N., Simpson, K., & Nahas, Z. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1033 · Cited by 74
Möller, H. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0689-8 · Cited by 73
Suicide and fatal antidepressant poisoning.
Henry, J. A., & Antao, C. A. (1992) · PubMed · Cited by 73
Hughes, S., Cohen, D., & Jaggi, R. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005535 · Cited by 72
Acute and Long-term Treatment of Late-Life Major Depressive Disorder: Duloxetine Versus Placebo
Robinson, M. J., Oakes, T. M. M., Raskin, J., Liu, P., Shoemaker, S., & Nelson, J. C. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.019 · Cited by 71
Schmidt, M. E., Fava, M., Robinson, J. M., & Judge, R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1107 · Cited by 68
Chronic and Treatment Resistant Depression
Bschor, T., Bauer, M., & Adli, M. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0766 · Cited by 67
Self-citationTerra, J.-L., & Montgomery, S. (1998) · PubMed · Cited by 66
Weihs, K. L., Houser, T. L., Batey, S. R., Ascher, J. A., Bolden-Watson, C., Donahue, R. M. J., & Metz, A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01317-8 · Cited by 65
Fava, G. A., Guidi, J., Rafanelli, C., & Sonino, N. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000366041 · Cited by 62
Mortality of 403 patients with mood disorders 48 to 52 years after their psychiatric hospitalisation
Angst, J., Hengartner, M. P., Gamma, A., Zerssen, D. V., & Angst, F. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0380-1 · Cited by 61
Kornstein, S. G., Bose, A., Li, D., Saikali, K. G., & Gandhi, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1115 · Cited by 60
Prophylactic efficacy of maprotiline on unipolar depression relapse.
Rouillon, F., Serrurier, D., Miller, H. D., & Gerard, M. J. (1991) · PubMed · Cited by 52
Terra, J. L., & Montgomery, S. A. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00001 · Cited by 51
From the Serotonin Model of Suicide to a Mental Pain Model of Suicide
de Leon, J., Baca-García, E., & Blasco-Fontecilla, H. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000438510 · Cited by 45
Maintenance study for adolescent depression
Cheung, A., Kusumakar, V., Kutcher, S., Dubo, E., Garland, J., Weiss, M., Kiss, A., & Levitt, A. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0001 · Cited by 44
Carpenter, D. J., Fong, R., Kraus, J. E., Davies, J. T., Moore, C., & Thase, M. E. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04927blu · Cited by 42
Rosenthal, J. Z., Boyer, P., Vialet, C., Hwang, E., & Tourian, K. A. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07974 · Cited by 37
Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?
El-Mallakh, R. S., & Briscoe, B. (2012) · CNS Drugs · doi:10.2165/11599450-000000000-00000 · Cited by 36
Kamijima, K., Burt, T., Cohen, G., Arano, I., & Hamasaki, T. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000182118.57510.d1 · Cited by 31
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
McGrath, P. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1542 · Cited by 31
Kamat, M. S. A., Edgar, L., Niblock, P., McDowell, C., & Kelly, C. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1357183 · Cited by 26
(2014) · Europe PMC (PubMed Central) · Cited by 24
Suicide with Psychotropic Drugs in Switzerland
Michel, K., Arestegui, G., & Spühler, T. (1994) · Pharmacopsychiatry · doi:10.1055/s-2007-1014289 · Cited by 22
Antidepressiva und Suizidalität
Gründer, G., Veselinovic, T., & Paulzen, M. (2014) · Der Nervenarzt · doi:10.1007/s00115-014-4092-9 · Cited by 14
Licht, R. W. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.009 · Cited by 11
Prophylactic effect of mianserin on recurrent depression
Kishimoto, A., Mizukawa, R., Matsuzaki, F., Hazama, H., Kamase, H., Tanaka, K., & Kunimoto, N. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01484.x · Cited by 11
A bold meta‐analysis on suicidality in bipolar disorder
Baethge, C. (2014) · Bipolar Disorders · doi:10.1111/bdi.12263 · Cited by 2
Self-citation
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Treatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256
Bipolar depression: a major unsolved challenge
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0160-1 · Cited by 235
Placebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205
Metadata
- Authors
- Braun, C., Bschor, T., Franklin, J., & Baethge, C.
- Affiliations
- University of Cologne (DE)
- Schlosspark-Klinik (DE)
- University Hospital Cologne (DE)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 3
- Pages
- 171-179
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2314831905
- Cited by
- 103
- References
- 71
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 10 · 2021: 15 · 2020: 12 · 2019: 9 · 2018: 10 · 2017: 5 · 2016: 6
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressants, suicide, suicide attempts, major depressive disorder, long-term treatment, relapse prevention, incidence rate ratio, adverse drug reactions
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Long-Term Care, Risk Factors, Suicide, Attempted, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.